Status: Recruiting
Safety and Efficacy Study of Collagenase CNT201 Injection for Treatment of Dupuytren's Contracture
This trial is a multicenter, Phase 1/2, study to assess the safety, tolerability, efficacy, PK, and immunogenicity of CNT201 in adult participants with DC (Dupuytren's Contracture).
Participants needed: 60
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: CONNEXTUpdated: Jun 12, 2026Locations: 1
Eligibility criteria
Men and women, 18 to 75 years of age, inclusive. [+5]
Participants previously exposed to collagenase Clostridium histolyticum for trea... [+8]